You need to enable JavaScript to run this app.
Recon: Vertex Prices Newly Approved CF Combo at $331K Per Year; Biogen to Seek Approval for Alzheimer’s Candidate
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher